68Ga-PSMA PET in the Renal Cell Carcinoma

Recruiting now · Not applicable

Conditions studied: Renal Cancer, Metastases, PSMA PET

In brief

The primary research purpose is to evaluate the diagnostic efficacy of 68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT. The second purpose is to evaluate whether 68Ga-PSMA PET can change the treatment decision of patients with locally advanced and advanced renal cell carcinoma

Key facts

Study ID
NCT04987086
Run by
Xijing Hospital
People needed
300
Starts
2021-06-01
Expected to finish
2027-12-01
Last updated by the study team
2026-03-11

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.